INS and type 1 diabetes mellitus: While this is shown in in vitro and animal studies, T1DM patients who are given exogenous insulin should technically gain in increased endogenous OCN synthesis, this would then be expected to stimulate pancreatic beta-cell proliferation and subsequent endogenous insulin secretion capabilities.